News
A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...
For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.
The brain busting side-effects of Ozempic-like fat jabs revealed – ‘slashing risk of silent killers’
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...
The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 percent lower in patients who took semaglutide compared to those who took ...
Gabapentin is routinely used to treat nerve pain and restless leg syndrome, but it might be riskier to our brain health than ...
People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
2h
NewsNation on MSNWeight loss drugs may lower risk of dementia, stroke: StudyBenefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results